These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26829213)

  • 1. Notch2 signaling promotes osteoclast resorption via activation of PYK2.
    Jin WJ; Kim B; Kim JW; Kim HH; Ha H; Lee ZH
    Cell Signal; 2016 May; 28(5):357-365. PubMed ID: 26829213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice.
    Gil-Henn H; Destaing O; Sims NA; Aoki K; Alles N; Neff L; Sanjay A; Bruzzaniti A; De Camilli P; Baron R; Schlessinger J
    J Cell Biol; 2007 Sep; 178(6):1053-64. PubMed ID: 17846174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
    Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH
    Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.
    Yeon JT; Ryu BJ; Choi SW; Heo JC; Kim KJ; Son YJ; Kim SH
    Amino Acids; 2014 Nov; 46(11):2605-14. PubMed ID: 25216923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of P2X7R-mediated Ca
    Ma Y; Zhao H; Chile C; Wang C; Zheng J; Song R; Zou H; Gu J; YanYuan ; Bian J; Liu Z
    Exp Cell Res; 2019 Oct; 383(2):111555. PubMed ID: 31415763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src kinase activity is essential for osteoclast function.
    Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
    J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption.
    Lakkakorpi PT; Bett AJ; Lipfert L; Rodan GA; Duong LT
    J Biol Chem; 2003 Mar; 278(13):11502-12. PubMed ID: 12514172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
    PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
    Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
    FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities.
    Shyu JF; Shih C; Tseng CY; Lin CH; Sun DT; Liu HT; Tsung HC; Chen TH; Lu RB
    Bone; 2007 May; 40(5):1329-42. PubMed ID: 17321230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1.
    Lee JM; Park H; Noh AL; Kang JH; Chen L; Zheng T; Lee J; Ji SY; Jang CY; Shin CS; Ha H; Lee ZH; Park HY; Lee DS; Yim M
    J Immunol; 2012 Dec; 189(11):5284-92. PubMed ID: 23109727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.
    Fukushima H; Nakao A; Okamoto F; Shin M; Kajiya H; Sakano S; Bigas A; Jimi E; Okabe K
    Mol Cell Biol; 2008 Oct; 28(20):6402-12. PubMed ID: 18710934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.